News

The ten founding companies include Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi. TransCelerate will work to identify and solve

Each company will contribute financial and other resources to meet the challenges faced by the company in developing new medicines. The TransCelerate members accepted objectives and guidelines for

Florax DS is formulated using a strain of the probiotic yeast called Saccharomyces Cerevisiae to provide temporary relief from occasional diarrhea, bloating, cramping, and gas within four hours.

ShangPharma will use Harbour’s human immunoglobulin-gene transgenic mice in Shanghai facility to provide fully human antibody development services to its clients. Licensed under the agreement to produce H2L2

The randomized placebo-controlled, double-blinded FACT 2 study has enrolled 300 subjects who will be randomized 1:1 to administer carboplatin and paclitaxel plus fosbretabulin versus carboplatin and paclitaxel plus

Ganetespib is a potent inhibitor of heat shock protein 90 (Hsp90), a molecular chaperone which is required for the proper folding and activation of many cancer-promoting proteins. The

The assay, which provides a biomarker/ diagnostic to know the use of approved therapies for multiple cancer indications, is used as a personalized medicinal treatment in Acute Myelogenous

By using a slow-moving mist, Combivent Respimat can deliver the same active ingredients as Combivent inhalation aerosol, which is delivered in a metered dose inhaler, combivent MDI. Boehringer

The study, which has recruited 22 patients, is designed to demonstrate the safety and efficacy of APR-246 in treating patients with advanced cancers. Escalating doses of APR-246 were